... have shown that the same traditional risk factors are involved in occurrence of obstructive CAD caused by atherosclerosis like dyslipidemia, arterial hypertension, smoking, obesity, and metabolic syndrome. Contribute to the development of CMD [ 3 ], the results of a single-center study performed on 245...

.... The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Dyslipidemia Cholesterol-lowering therapy HMGCoAreductase inhibition Cardiovascular outcomes...

..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Acute coronary syndrome Dyslipidemia Drug therapy Cardiovascular...

... that dyslipidemia was associated with adult height in Korean men without CVD. Objectives: This study explored the potential -relationship between height and dyslipidemia in premenopausal women. Methods: This study used data from the 2007–2016 Korea National Health and Nutritional Examination Survey (KNHANES). We...

... healthy male with mixed dyslipidemia. He developed bilateral myalgia of the forearms with fluvastatin 40 mg/day, pravastatin 20 mg/day, and combination of atorvastatin 10 mg and ezetimibe 10 mg/day. The only hypolipidemic treatment that was tolerable was the combination of pitavastatin 1 mg and ezetimibe...

... with dyslipidemia. Conclusions: Approximately two fifths of statin-treated patients with CVD are not reaching lipid goals or have abnormal lipid levels, while patients with PAD could particularly benefit from improved lipid management. In addition to targeting LDL-C, new evidence-based approaches are needed...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Dyslipidemia Endothelial function Ezetimibe Forearm blood flow Metabolic syndrome Statin therapy Lipid-lowering therapy...

...Dirk Devroey; Karolien Vantomme; Willem Betz; Jan Vandevoorde; Jan Kartounian This paper aims to review the guidelines on the importance given to high-density lipoprotein cholesterol (HDL-C) as a risk factor or as threshold and target level in the treatment of dyslipidemia. We developed a strategy...

... dyslipidemia, including diabetic patients, and may constitute a monotherapy option for many such patients. Rosuvastatin is well tolerated when used alone or in combination, exhibiting a safety profile similar to that of other available statins. Rosuvastatin offers considerable advantages for use in routine...

.... Coronary disease, prevention/control Dyslipidemia High-density lipoprotein cholesterol Lipid-lowering therapy Treatment outcome We report the case of a 60-year-old male with a history of essential hypertension since 1989. He had no family history of cardiovascular disease. At that time he...